- Home
- TPST vs WAI Comparison
TPST vs WAI Comparison
Compare TPST & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- WAI
- Stock Information
- Founded
- TPST 2011
- WAI 2018
- Country
- TPST United States
- WAI China
- Employees
- TPST N/A
- WAI N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- WAI
- Sector
- TPST Health Care
- WAI
- Exchange
- TPST Nasdaq
- WAI NYSE
- Market Cap
- TPST 33.0M
- WAI 33.5M
- IPO Year
- TPST N/A
- WAI 2023
- Fundamental
- Price
- TPST $7.52
- WAI $0.48
- Analyst Decision
- TPST Hold
- WAI
- Analyst Count
- TPST 3
- WAI 0
- Target Price
- TPST $30.00
- WAI N/A
- AVG Volume (30 Days)
- TPST 125.6K
- WAI 1.7M
- Earning Date
- TPST 08-07-2025
- WAI 08-24-2025
- Dividend Yield
- TPST N/A
- WAI N/A
- EPS Growth
- TPST N/A
- WAI N/A
- EPS
- TPST N/A
- WAI N/A
- Revenue
- TPST N/A
- WAI $3,750,352.00
- Revenue This Year
- TPST N/A
- WAI N/A
- Revenue Next Year
- TPST N/A
- WAI N/A
- P/E Ratio
- TPST N/A
- WAI N/A
- Revenue Growth
- TPST N/A
- WAI N/A
- 52 Week Low
- TPST $5.35
- WAI $0.46
- 52 Week High
- TPST $30.03
- WAI $20.00
- Technical
- Relative Strength Index (RSI)
- TPST 57.33
- WAI N/A
- Support Level
- TPST $7.06
- WAI N/A
- Resistance Level
- TPST $7.18
- WAI N/A
- Average True Range (ATR)
- TPST 0.27
- WAI 0.00
- MACD
- TPST 0.05
- WAI 0.00
- Stochastic Oscillator
- TPST 88.57
- WAI 0.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).